31P-MRS and Huntington Disease (NCT01359774) | Clinical Trial Compass
CompletedNot Applicable
31P-MRS and Huntington Disease
France30 participantsStarted 2011-04
Plain-language summary
The purpose of this study is to identify and quantify a brain energy deficit in Huntington patients, using 31P-RMN spectroscopy.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 5\<UHDRS\<50
* Age\>18 years
* Ability to undergo MR scanning
* Covered by french social security
Exclusion Criteria:
* Evidence of psychiatric disorder
* Attendant neurological disorder
* Contraindications to MRI (claustrophobia, metallic or material implants)
* Severe head injury
* Unable to understand the protocol
* Pregnancy
* Failure to give informed consent
* Subjects with exclusion criteria required by french law (e.g. subjects who require a legally authorized representative to obtain consent)
* Unwillingness to be informed in case of abnormal MRI
What they're measuring
1
Brain energy deficit in Huntington patients
Timeframe: one year
Trial details
NCT IDNCT01359774
SponsorInstitut National de la Santé Et de la Recherche Médicale, France